乳腺癌中的表观遗传重编程:CRISPR-Cas 9的作用
1Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Bulletin du cancer
|June 13, 2025
概括
通过编辑表观遗传变化,CRISPR-Cas9技术提供了打击乳腺癌 (BC) 的新方法. 这种方法可以重新激活瘤抑制基因并抑制瘤基因,以获得更好的治疗结果.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 表观遗传改变是乳腺癌 (BC) 发展和进展的关键驱动因素.
- 乳腺癌仍然是一个重大的全球健康问题,需要创新的治疗策略.
研究的目的:
- 审查CRISPR-Cas9技术用于抗击乳腺癌的表观遗传修饰的应用.
- 探索CRISPR-Cas9在开发有针对性和个性化的BC疗法的潜力.
主要方法:
- 检查CRISPR-Cas9及其衍生物 (例如dCas9) 以向DNA甲基化和基因素修饰.
- 基于CRISPR的表观遗传编辑策略用于BC治疗的分析.
主要成果:
- 克里斯普尔-Cas9可以精确地改变表观遗传情景,包括DNA甲基化和基因素修饰.
- 这项技术显示出在重新激活已被静止的瘤抑制基因和抑制BC中的瘤基因方面的潜力.
结论:
- 以CRISPR-Cas9为媒介的表观遗传编辑为向乳腺癌治疗提供了一种革命性的方法.
- 与现有和新兴疗法的整合可以提高治疗疗效和克服耐药性,改善患者的生存率.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
209
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.5K
相关概念视频
CRISPR
50.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.0K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Homologous Recombination
50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
